VASCULAR SOLUTIONS D-STAT FLOWABLE HEMOSTAT 4000 0330

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2003-04-14 for VASCULAR SOLUTIONS D-STAT FLOWABLE HEMOSTAT 4000 0330 manufactured by Vascular Solutions, Inc..

Event Text Entries

[15372954] The d-stat flowable hemostat was deployed to seal the tissue tract following a liver biopsy. The pt immediately experienced a seizure. The pt's vital statistics were monitored until the event was resolved.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2134812-2003-00377
MDR Report Key453772
Report Source05,07
Date Received2003-04-14
Date of Report2003-04-14
Date of Event2003-03-18
Date Mfgr Received2003-03-18
Date Added to Maude2003-04-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactLINDA BUSKLEIN, SR. ASSOCIATE
Manufacturer Street6464 SYCAMORE COURT
Manufacturer CityMINNEAPOLIS MN 55369
Manufacturer CountryUS
Manufacturer Postal55369
Manufacturer Phone7636564300
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVASCULAR SOLUTIONS D-STAT FLOWABLE HEMOSTAT
Generic NameTOPICAL HEMOSTAT
Product CodeMHW
Date Received2003-04-14
Model Number4000
Catalog Number0330
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key442774
ManufacturerVASCULAR SOLUTIONS, INC.
Manufacturer Address6464 SYCAMORE COURT MINNEAPOLIS MN 55369 US
Baseline Brand NameD-STAT FLOWABLE HEMOSTAT
Baseline Generic NameTOPICAL HEMOSTAT
Baseline Model No4000
Baseline Catalog NoNA
Baseline IDNA
Baseline Device FamilyNA
Baseline Shelf Life Contained*
Baseline Shelf Life [Months]12
Baseline PMA FlagY
Premarket ApprovalP9900
Baseline 510K PMNY
Premarket NotificationK012293
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2003-04-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.